Hanmi

South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug d...

Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...

South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...

Hanmi Semiconductor Co., South Korea’s leading chip equipment maker, has launched a ‘full automation glass micro saw' dubbed GL2101 and ...

Digital Pharm, jointly invested in by KT Corp. and Hanmi Pharmaceutical Co., held an official inauguration ceremony last week, the company announced...

Hanmi Semiconductor Co., a South Korean chip equipment manufacturer, has been chosen as one of the world’s top 10 chip fabrication machine mak...

The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...

South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...

South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...

Hanmi Semiconductor Co., a chip equipment supplier to global foundry leader Taiwan Semiconductor Manufacturing Co. (TSMC), has posted record profit ...

Hanmi Pharmaceutical said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug dis...